GeneDx Holdings Corp. (WGS)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$85.99-1.60%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · WGS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 454.4 | 427.5 | 305.5 | 202.6 | 234.7 | 212.2 | 179.3 |
| Cost of Revenues | 139.2 | 129.4 | 111.1 | 112.6 | 261.4 | 228.8 | 175.3 |
| Gross Profit | 315.2 | 298.2 | 194.4 | 90.0 | (26.8) | (16.6) | 4.0 |
| Operating Expenses & Income | |||||||
| R&D Expenses | 83.8 | 72.0 | 45.7 | 58.3 | 86.2 | 105.2 | 72.7 |
| Other Operating Expenses, Total | — | — | (3.4) | (2.0) | (6.3) | — | — |
| Operating Income | (92.4) | (13.1) | (23.2) | (180.6) | (667.7) | (446.1) | (242.0) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | — | — | 3.2 | 2.8 | 2.5 |
| Interest & Investment Income | — | — | — | — | 2.5 | 0.1 | 0.5 |
| Net Interest Expenses | — | — | — | — | 0.7 | 2.8 | 2.0 |
| Other Non-Operating Income / Expenses | (13.9) | (8.1) | (29.4) | 3.9 | 69.6 | 200.8 | 0.7 |
| Asset Writedown | — | — | — | 10.4 | 210.1 | 0.0 | 0.0 |
| EBT, Incl. Unusual Items | (106.3) | (21.1) | (52.6) | (176.7) | (598.0) | (245.4) | (241.3) |
| Income Tax Expense | 0.1 | (0.1) | (0.3) | (0.9) | (49.1) | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (106.3) | (21.0) | (52.3) | (175.8) | (549.0) | (245.4) | (241.3) |
| Per Share | |||||||
| Basic EPS | (3.58) | (0.73) | (1.94) | (7.23) | (53.63) | (2.27) | — |
| Diluted EPS | (3.58) | (0.73) | (1.94) | (7.23) | (53.63) | (2.27) | — |
| Revenue per Share | 15.30 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 29.7 | 28.6 | 26.9 | 24.3 | 10.2 | 108.1 | 0.0 |
| Diluted Weighted Avg Shares | 29.7 | 28.6 | 26.9 | 24.3 | 10.2 | 108.1 | 0.0 |
| Supplemental | |||||||
| EBITDA | — | (3.5) | (15.3) | (160.9) | (617.7) | (424.3) | (230.3) |
| EBIT | (92.4) | (13.1) | (23.2) | (180.6) | (667.7) | (446.1) | (242.0) |
| Effective Tax Rate | -0.1% | — | — | 0.5% | 8.2% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.